Suivant

Lecture automatique

Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma

5 Vues • 08/09/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique